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WHAT THIS PAPER ADDS
This study introduces a new visual grading score that improves the accuracy of FDG-PET/CT in the detection of
prosthetic vascular graft infections (PVGIs). This will not only improve and speed up the diagnosis of PVGI but
also allow for the monitoring of medical and surgical therapy thereof. Morbidity, mortality, and costs of
treatment may signiﬁcantly decrease in the near future because of the enhanced diagnostic accuracy and
improved therapeutic management.
Objective: The aim of this study was to evaluate the diagnostic accuracy of positron emission tomography/
computed tomography with 18F-ﬂudeoxyglucose (FDG-PET/CT) in a population with suspected graft infection and
to validate a new diagnostic imaging score for FDG-PET/CT.
Methods: This was a prospective cohort study. FDG-PET/CT was performed prospectively in 34 patients with
suspected graft infection, in 12 of them before the start of antimicrobial treatment. Diagnostic accuracy was
assessed using a new ﬁve point visual grading score and by using a binary score. Maximum standardized uptake
values (SUVmax) were calculated for quantitative measurements of metabolic activity, and cut off points were
calculated using the receiver operator curve (ROC). The standard of reference was a microbiological culture,
obtained after open biopsy or graft explantation.
Results: Using the new scale, FDG-PET/CT correctly recognized 27 patients with graft infection, one patient was
diagnosed as false positive, six patients were correctly classiﬁed as true negative, and no patients were rated
false negative. Hence, sensitivity, speciﬁcity, positive predictive value (PPV), negative predictive value (NPV), and
accuracy of FDG-PET/CT for the diagnosis of graft infections were 100%, 86%, 96%, 100%, and 97%, respectively.
Using a previously established binary score, sensitivity, speciﬁcity, PPV, NPV, and accuracy were 96%, 86%, 96%,
86%, and 94% respectively. ROC analysis suggested an SUVmax cut off value of 3.8 to differentiate between
infected and non-infected grafts (p < .001). Additionally, FDG-PET/CT provided a conclusive clinical diagnosis in
six of seven patients without graft infection (i.e., other sites of infections).
Conclusions: The diagnostic accuracy of FDG-PET/CT in the detection of aortic graft infection is high. A newly
introduced ﬁve point visual grading score and early imaging prior to antimicrobial treatment may further improve
the diagnostic accuracy.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Vascular graft infections, although relatively rare (incidence
rate between 1% and 6%)1 require an immediate and deﬁnite
diagnosis2 as they carry a high mortality and morbidity risk.3
In 2005, a ﬁrst report on the diagnostic accuracy of positron
emission tomography/computed tomography (PET/CT) with
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http://dx.doi.org/10.1016/j.ejvs.2014.12.02418F-ﬂudeoxyglucose (FDG) suggested an increased accuracy
of FDG-PET/CT compared with the current standard contrast
enhanced CT in the diagnostic assessment of patients with
suspected vascular graft infection.4 Since then other groups
have reconﬁrmed the higher sensitivity of PET/CT in the
detection of graft infections.4e7
Signs of graft infection on PET/CT imaging are ﬂuid for-
mations or fat stranding and/or FDG avid lesions adjacent to
the graft, as FDG accumulates in metabolically active cells
and thus detects infectious tissues.8 Increased glucose
metabolism may be detected earlier and/or in less severe
stages of infectious processes by PET/CT than graft thick-
ening, perigraft soft tissue enhancement, pseudoaneurysm
formation, or gas collection typically detected by CT imaging,
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fectious process. The higher sensitivity of FDG-PET/CT than
CT imaging has led to a lower speciﬁcity and false positive
(FP) rate, both of which are often the consequence of foreign
body reactions caused by the graft.9 Knowledge of typical
FDG uptake patterns of foreign body reactions,10 a mildly
increased and not focal FDG uptake along the graft, may
prevent FP imaging interpretation.
Today, data on diagnostic accuracy of FDG-PET/CT in the
detection of vascular graft infections are still scarce and
comparability is hampered by the variability of patient
populations, imaging protocols, and time points of imag-
ing4e7 (Table 1). Additionally, data on the perigraft maximum
standardized uptake value (SUVmax), a semi-quantitative in-
dex of graft infection, are still limited.11 More studies are
required to deﬁne the diagnostic accuracy of FDG-PET/CT,
justifying the use of this more complex and expensive
technique in routine practice. The diagnostic accuracy of
FDG-PET/CT in a well-deﬁned prospective cohort of patients
with suspected graft infections using microbiologic results as
the standard of reference was assessed. An additional aim
was to validate a new diagnostic imaging score for FDG-PET/
CT, which may help to further increase its speciﬁcity.
METHODS
Study design and data collection
The Vasgra (vascular graft) Cohort Study is a prospective
observational cohort study with ongoing enrolment of pa-
tients, aged >18 years receiving any type of vascular graft
operation at the University hospital of Zurich. Standardized
data collection forms on the index vascular operation, de-
mographic, clinical, laboratory, and follow up information are
completed every 6 months by physicians and study nurses.
The Vasgra Cohort was approved by the local Institutional
Ethics Committee. New prosthetic vascular graft infections
(PVGIs) as well as foreign body reaction, bleeding, throm-
bosis, and arterial disruption of vascular grafts have been
documented sinceMay 1, 2013. Endpoints are core reviewed
and validated by a team of vascular surgeons and infectious
disease specialists. Diagnosis of PVGI followed the deﬁnition
proposed by FitzGerald et al.12 The gold standard for PVGI
diagnosis was a positive microbiological culture of the deep
tissue around the vascular prosthesis obtained by open bi-
opsy, or a positive microbiological culture of an explanted
vascular graft. However, clinical, laboratory, and histopath-
ological results were also taken into account. Surgical clas-
siﬁcations of PVGI were done according to the Szilagyi
criteria.13 As per protocol, patients with suspected vascular
graft infection received a combined FDG-PET/CT prior to
antimicrobial treatment, or as soon as possible after the start
of either surgical or antimicrobial treatment.
Patient population
This study was a prospective analysis of consecutive pa-
tients undergoing combined FDG-PET/CT between May
2013 and May 2014 at our institution. Thirty-four patients(3 women, 31 men; median [IQR] age 67 [62e76] years)
with suspected vascular graft infection were enrolled.
FDG-PET/CT was successfully performed with diagnostic
image quality in all 34 patients with suspected vascular
graft infections. Baseline characteristics are presented in
Table 2. Twenty patients underwent open vascular surgery.
The index surgical operation included total arch or
descending aorta replacement (n ¼ 8), aorto-bi-iliac graft
(n ¼ 7), femoro-femoral crossover bypass (n ¼ 3), and ilio-
femoral or femoro-tibial bypass (n ¼ 2). Fourteen patients
had endovascular aortic repair of either abdominal (EVAR,
n ¼ 5) or thoracic aortic aneurysms (TEVAR, n ¼ 5), or they
had an endovascular placement of a stent graft in the iliac
artery (n ¼ 4). The median (IQR) time between initial
operation and inclusion in the present study was 213 (63e
644) days. Inclusion in the study in the case of endovascular
surgery was a median (IQR) 70 (35e593) days and for open
surgery 443 (110e671) days after the index operation.
PET/CT data acquisition
Patients fasted for at least 4 hours and had no insulin in-
jections 4 hours prior to FDG administration. Body weight,
height, and blood glucose levels were measured prior to
injection of FDG. In non-diabetic patients, blood glucose
levels <8 mmol/L and in diabetic patients blood glucose
levels <12 mmol/L were accepted for imaging. After
intravenous injection of body weight adapted FDG, patients
rested for a standardized uptake time of 60 minutes. All
scans were performed on an integrated PET/CT system
(Discovery VCT; GE Healthcare, Milwaukee, WI, USA).
Data were acquired with the patient in the supine position
with arms overhead. Low dose CT for attenuation correction
was acquired from the mid-thigh to the vertex of the skull
with the following scan parameters: tube voltage, 140 kVp;
tube current time product, 10e80 mAs/slice; pitch of 1.4;
collimation, 64  0.625 mm; rotation time, 0.5 ms; and ﬁeld
of view (FOV), 50 cm. Directly after CT data acquisition, PET
data were acquired using the three dimensional mode (3D)
with a ﬁxed scan duration of 2minutes per bed position and a
FOV of 157 mm. Emission data were corrected for randoms,
dead time, scatter, and attenuation. CT data for attenuation
correction and anatomical referencing were reconstructed
with a slice thickness of 3.75mmand an increment of 3.0mm
using a ﬁltered back reconstruction algorithm. Attenuation
corrected axial PET images were reconstructed using a
standard iterative ordered subset expectation maximization
(OSEM) 3D algorithm (matrix size, 256  256, Fourier
rebinning, 3D OSEM with 8 iterations, 16 subsets).
Image analysis
All FDG-PET/CT images were independently analyzed by two
experienced nuclear medicine physicians (B.S. and L.H.) on
an AW Workstation Version 4.4 (GE Healthcare Biosciences,
Pittsburgh, PA, USA). Readers were blinded to all clinical
patient data. Whole body datasets were analyzed for sec-
ondary diagnosis, that is, infectious foci not in the vicinity of
a graft, or other relevant or malignant ﬁndings.
Table 1. Summary of FDG-PET/CT studies on vascular graft infections.
Author Year Patients Grafts Methodology Assessment of PET Sensitivity Speciﬁcity PPV NPV Accuracy
Fuckuchi et al.4 2005 33 patients
9 acute infections
2 low-grade infections
Aortic Prospective Density of uptake
Grade 0e4
91% 64% 56% 93% 73%
Pattern of uptake
Focal
Diffuse
91% 95% 91% 95% 94%
Keidar et al.5 2007 39 patients
12 acute infections
2 low-grade infections
Aortic and peripheral
grafts
Prospective Pattern of uptake
Focal
Diffuse
93% 91% 88% 96%
Spacek et al.6 2009 76 patients with 96 grafts
55 low grade infections
Aortic and peripheral
grafts
Prospective Pattern of uptake
Focal (without inhomogeneous group)
Diffuse
78.2% 92.7% 93.5% 76.0% 84.4%
Pattern of uptake
Focal (with inhomogeneous group)
Diffuse
98.2% 75.6% 84.4% 96.9% 88.5%
Graft to blood uptake ratio 1.7443 74.5% 82.9%
Bruggink et al.7 2010 25 Patients
11 acute infections
4 low-grade infections
Aortic and peripheral
grafts
Prospective Density of uptake
Scale IeIV
93% 70% 82% 88%
Tissue-to-background ratio 3.4 (2.8e7.2)
SUVmax 4 (2.7e6.0)
Tokuda et al.11 2013 9 Patients
4 low grade infections
Aortic Retrospective SUVmax >8
SUVmax, not infected: 6.9  6.4
SUVmax, infected: 11.4  4.5
100% 80%
Present study 2014 30 Patients
16 acute infections
7 low grade infections
Aortic and peripheral
grafts
Prospective Pattern
Focal/
Diffuse
96% 75% 93% 86% 91%
5 point visual grading score grades 1e5 100% 75% 90% 100% 94%
SUVmax > 3.7 100% 75%
PPV ¼ positive predictive value; NPV ¼ negative predictive value; SUVmax ¼ maximum standardized uptake value.
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Table 2. Baseline characteristics of 34 individuals with suspected graft infections.
Patient no. Age Sex Procedure Type of index operation Type of graft Graft age
(days)
Reason for referral Microbiology Diagnosis
1 76 M Endovascular Stent graft iliac artery PTFE 1148 CT ﬁnding Escherichia coli PVGI
2 63 M Open Y graft PTFE 188 Laboratory
Fatigue
Enterococcus faecalis
Candida albicans
PVGI
3 48 M Open Total aortic arch replacement Polyester 25 Fever
Sternal pain
Coagulase negative Staphylococci
Propionibacterium acnes
PVGI
4 52 M Endovascular Stent graft iliac artery PTFE 70 Pain Propionibacterium acnes
Streptococcus spp.
PVGI
5 74 M Open Femoro-femoral crossover bypass Dacron 443 Abscess groin Staphylococcus aureus PVGI
6 63 M Open Aortic root and arch replacement Polyester 644 Retrosternal abscess
formation
Non-tuberculous mycobacteria PVGI
7 68 M Open Femoro-femoral crossover bypass PTFE 66 Secreting groin wound Coagulase negative Staphylococci
Prevotella bivia
Finegoldia magna
Granulicatella adjacens
PVGI
8 56 M Open Y graft Dacron 671 Groin ﬁstula Staphylococcus aureus
Escherichia coli
Klebsiella sp.
PVGI
9 51 M Open Bypass superﬁcial femoral artery
to anterior tibial artery
Vein 351 Abscess calf Streptococcus sp
Escherichia coli
PVGI
10 79 M Open Y graft na 4253 Ischemic leg pain
Laboratory
Culture negative PVGI
11 71 M Endovascular EVAR
Aorto-bi-iliac stent graft
PTFE 35 Abdominal pain Coagulase negative Staphylococci PVGI
12 71 M Open Aortic root and total arch
replacement
Polyester 610 Retrosternal abscess
CT ﬁnding
Streptococcus gordonii PVGI
13 62 M Endovascular Aorto-bi-iliac sten -graft PTFE 593 Fever
CT ﬁndings
Streptococcus dysgalactiae PVGI
14 61 M Open Aortic root and total arch
replacement
Polyester 464 Fever
Laboratory
Back pain
Non-tuberculous mycobacteria PVGI
15 62 M Open Y graft Silvergard 111 Aortic aneurysm Escherichia coli
Bacteroides fragilis
PVGI
16 62 M Endovascular Aorto-bi-iliac stent graft PTFE 242 Gastroduodenal ﬁstula Enterobacter
Enterococcus faecium
Klebsiella pneumoniae
Candida glabrata
PVGI
17 81 W Open Aortic root and total arch
replacement
Biograft 110 Sternal wound infection
Mediastinitis
Coagulase negative Staphylococci
Propionibacterium acnes
Serratia marcescens
PVGI
18 63 M Open Femoro-femoral crossover bypass PTFE 2103 Pseudoaneurysm
Bleeding
Coagulase negative Staphylococci
Candida albicans
PVGI
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19 70 M Open Y graft PTFE 137 Graft contamination after
abdominal surgery and
post-operative abscess
formation
Enterococcus faecium PVGI
20 71 M Endovascular TEVAR, 0e4 PTFE 63 Aortic aneurysm Streptococcus dysgalactiae PVGI
21 81 M Open Y graft na 5381 Fever
Laboratory
PVGI
22 53 M Open Aortic root and total arch
replacement
Polyester 624 Fever Pasteurella multocida PVGI
23 77 F Open Ilio-femoral bypass Silvergard 2 Cellulitis, wound infection,
fever
Coagulase negative Staphylococci PVGI
24 80 M Endovascular TEA right AFC, thoraco-abdominal
EVAR
PTFE 57 Groin wound infection,
hematoma
Citrobacter koseri, Enterococcus
faecalis, Bacteroides fragilis
PVGI
25 66 M Open Y graft PTFE 2150 Aorto-duodenal ﬁstula Enterococcus faecalis, Enterobacter
aerogens, Streptococccus equinus
PVGI
26 66 M Endovascular TEVAR, 0e4 PTFE 238 Paraaortal hematoma,
Laboratory
Coagulase negative Staphylococci PVGI
27 51 M Endovascular EVAR thoraco-abdominal Dacron 983 Gastroduodenal ﬁstula Streptococcus gallolyticus,
Pediococcus acidilactici, Candida
albicans
PVGI
28 78 M Endovascular TEVAR 1e4 PTFE 68 Fever
Laboratory
e Pneumonia
29 74 M Endovascular EVAR
Aorto-bi-iliac stent graft
PTFE 90 Fever e Diverticulitis
30 79 W Endovascular TEVAR 2e4 PTFE 10 Fever
Laboratory
Back pain
e Spondylodiscitis
31 33 M Open Descending aorta replacement Na 4005 Fever
Abdominal pain
e Colitis
32 82 M Endovascular EVAR
Aorto-bi-iliac stent graft
PTFE 31 Septic shock Clostridium
difﬁcile colitis
33 76 M Open Aortic arch replacement Polyester 59 Fever
Laboratory
e Dressler syndrome
34 65 M Endovascular TEVAR, 2e4 PTFE 31 Fever
Laboratory
e Sinusitis
M, male; F, female; TEVAR, thoracic aortic repair; EVAR, endovascular aortic repair; PTFE, polytetraﬂuoroethylene; PVGI, prosthetic vascular graft infection; na, not applicable.
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460 B.-R. Sah et al.Two different subjective imaging scores were used to
establish or to rule out PVGI: The ﬁrst, established, score
considered the FDG uptake pattern in the graft: focal uptake
was considered as infectious, while diffuse FDG uptake was
considered to be non-infectious (e.g., foreign body reac-
tion).4 The second score was a new semi-quantitative
assessment using a new ﬁve point visual grading score,
which took into account the FDG uptake patterns and CT
information as follows: grade 1, normal background activity;
grade 2, mildly increased, but diffuse FDG uptake along the
graft (mild uptake: less than twice the blood pool activity in
the ascending aorta; strong uptake: more than twice the
blood pool activity in the ascending aorta); grade 3, focal, but
only mild FDG uptake or strong diffuse FDG uptake along the
graft; grade 4, focal and intense FDG uptake (diffuse FDG
uptake along the graft); grade 5, focal and intense FDG uptake
plus ﬂuid collections/abscess formation. Imaging examples
for each score are presented in Fig. 1. Score values of 3, 4, and
5were considered to be positive for graft infection, and score
values of 1 and 2 as negative. Final scores for further analysis
were deﬁned by consensus reading.
For quantitative measurements of metabolic activity of
the tracer in all grafts SUVmax was calculated using in-built
software.
Statistical analyses
Statistical analysis was performed using commercially
available software (Stata, Version 13, StataCorp, College
Station, TX, USA).Figure 1. Five point visual grading score for prosthetic vascular graft in
(top left panel); grade 2, mildly increased, but diffuse FDG-uptake alon
or strong diffuse FDG-uptake along the graft (below, left panel); grad
graft) (below, panel in the middle); grade 5, focal and intense FDG-uSensitivity, speciﬁcity, negative predictive values (NPVs),
and positive predictive values (PPVs)were determined for the
diagnosis of vascular graft infections with the use of a binary
and a ﬁve point visual grading score considering the criteria
described in the method section. Inter-observer agreements
were evaluated for both the binary and the 5 point Linkert
scale scoring systemwith Cohen’s kappa statistics. Results for
inter-observer agreement were construed in accordancewith
the classiﬁcation of Landis and Koch14 as follows: values of 0.2
or less as poor, values of 0.21e0.4 as fair, values of 0.41e0.6
asmoderate, values of 0.61e0.8 as good, and values of 0.81e
1.0 as excellent agreement; in case of disagreement a
consensus reading was performed. The SUVmax cut point at
the receiver operator curve (ROC) yielding the highest accu-
racy of PVGI diagnosis was determined.
RESULTS
Twenty-seven of 34 patients (79%) had a microbiologically
proven Szilagyi III graft infection; one patient with antibiotic
pre-treatment remained culture negative, although histo-
pathological ﬁndings showed clear evidence of graft infec-
tion. In seven patients (21%) graft infection was ruled out.
Twelve patients (35%) did not receive any antibiotic treat-
ment prior to FDG-PET/CT, while in 22 patients (65%)
antibiotic treatment had already started (median 13 days
[IQR 6e72] days) prior to imaging. Owing to fulminant
clinical presentation at the time of diagnosis, three patients
were scanned after urgent surgical intervention. Median
(IQR) C-reactive protein was 35.5 (17e85) mg/L, beingfection. Five point visual grading score: grade 1, background activity
g the graft (top right panel); grade 3, focal, but only mild FDG-uptake
e 4, focal and intense FDG-uptake (diffuse FDG-uptake along the
ptake plus ﬂuid collections/abscess formation (below right panel).
Diagnostic Performance of 18F-FDG-PET/CT 461higher in patients without graft infection (26 [14e74] mg/L
vs. 85 [67e169] mg/L; Wilcoxon rank-sum p ¼ .011).
Diagnostic performance
Using a ﬁve point visual grading score of graft infections,
reader 1 (L.H.) and reader 2 (B.S.) scored images as shown in
Table 3. Both readers scored the same six patients negative
and the same 24 positive for vascular graft infections. Inter-
observer agreement for the ﬁve point visual grading score
was good (k ¼ .72, p < .001) with differences occurring be-
tween scores of 1 and 2 (n ¼ 1) as well as between score 3
and 4 (n ¼ 1) and between scores of 4 and 5 (n ¼ 5).
FDG-PET/CT correctly recognized 27 cases with graft infec-
tion as true positive (TP) using the ﬁve point visual grading
score. One patient was diagnosed FP, six patients were
correctly classiﬁed as true negative (TN), and no patients wereTable 3. FDG PET/CT characteristics and results of images analysis.
Patient
no.
Diabetes
1 ¼ yes
Blood glucose at
time of PET (mmol/L)
CRP
(mg/
L)
WBC
count (g/L)
1 0 6.3 19 5.83
2 0 6 17 6.01
3 0 5.2 202 6.63
4 0 5.1 159 7.75
5 0 7 5.6 9.93
6 0 4.6 26 3.03
7 0 5.1 1.7 6.84
8 1 8.8 50 8.83
9 0 6.7 36 8.46
10 0 4.7 17 5.69
11 1 5.7 120 11.93
12 0 4.5 30 6.87
13 1 9.8 3.4 6.14
14 0 5.9 33 2.99
15 0 5.8 23 9.71
16 0 7.9 40 4.91
17 0 6.8 2.1 6.2
18 0 6.2 74 9.65
19 0 6.1 0.8 5.12
20 1 5.8 35 4.65
21 0 5.2 85 9.21
22 0 5.1 114 6.68
23 0 5.5 24 8.01
24 0 6.4 4.9 5.80
25 0 5.7 217 10.1
26 0 5.8 14 6.19
27 0 7.3 17 8.72
28 0 5.3 129 6.21
29 0 5.7 85 7.03
30 0 6.8 190 10.17
31 0 5.2 68 12.01
32 1 10.5 37 6.24
33 0 5.5 169 1.81
34 0 5.5 67 7.61
PET ¼ positron emission tomography/computed tomography (PET
MBq ¼ megabecquerel; WBC ¼ White blood cell count; CRP ¼
max ¼ maximum standardized uptake value; Y ¼ yes; N ¼ no.
a Five point visual grading score: grade 1, background activity; grade
focal, but only mild FDG-uptake or strong diffuse FDG-uptake along th
along the graft); grade 5, focal and intense FDG-uptake plus ﬂuid corated false negative (FN) by both readers (patients without
antibiotic treatment: TP¼ 9, FP¼ 0, TN¼ 3, FN¼ 0; patients
on antibiotic treatment: TP¼ 18, FP¼ 1,TN¼ 3, FN¼ 0). ROC
analysis provided an area under the curve (AUC) of 0.99
(standard error 0.01). Overall sensitivity, speciﬁcity, PPV, NPV,
and accuracy of PET/CT for the diagnosis of graft infections
with the use of a ﬁve point visual grading score (score  3):
100% (95% CI: 87e100), 86% (42e100), 96% (82e100), 100%
(54e100), and 97% (85e100); patients without antibiotic
treatment: 100% (66e100), 100% (29e100), 100% (66e100),
100% (29e100), and 100% (74e100); patients with antibiotic
treatment: 100% (82e100), 75% (19e99), 95% (74e100),
100% (29e100), 96% (77e100).
Focal FDG uptake was found in 27 patients and diffuse
uptake in seven patients, resulting in 26 TP, six TN, one FP,
and one FN ﬁnding; thus the calculated sensitivity,Score
reader 1a
Score
reader 2a
PET
ﬁndings
SUVmax
18F-
FDG
(MBq)
AB therapy
before PET
4 4 TP 14.4 385 N
4 4 TP 6.2 326 N
5 5 TP 9.5 340 N
5 5 TP 17.8 342 N
3 3 TP 3.8 220 Y
5 5 TP 8.5 398 N
3 4 TP 5.2 405 N
4 4 TP 5.4 344 N
5 5 TP 6.7 398 N
3 3 TP 4.4 221 Y
5 5 TP 10.1 341 N
5 5 TP 10 349 Y
5 5 TP 10.2 328 Y
5 5 TP 7.6 402 Y
3 3 TP 5.4 348 Y
4 5 TP 7.2 261 Y
4 5 TP 10.6 281 Y
4 4 TP 5.8 240 Y
4 4 TP 5.9 310 Y
5 4 TP 8.2 403 Y
5 5 TP 16.7 316 Y
4 4 TP 7.5 387 Y
3 3 TP 4.0 306 Y
4 4 TP 6.4 324 Y
4 5 TP 6.5 417 Y
4 4 TP 6.4 331 Y
4 5 TP 6.1 360 N
1 1 TN 3.4 364 N
2 1 TN 3.2 248 N
1 1 TN 2.6 252 N
3 3 FP 4.6 258 Y
2 2 TN 3.2 401 Y
1 1 TN 3.6 306 Y
1 1 TN 2.8 258 Y
/CT) with 18 ﬂudeoxyglucose (FDG); AB ¼ antimicrobial therapy;
C-reactive protein; TP ¼ true positive; TN ¼ true negative; SUV
2, mildly increased, but diffuse FDG-uptake along the graft; grade 3,
e graft; grade 4, focal and intense FDG-uptake (diffuse FDG-uptake
llections/abscess formation.
462 B.-R. Sah et al.speciﬁcity, PPV, NPV, and accuracy of PET/CT was 96% (81e
100), 86% (42e100), 96% (81e100), 86% (42e100) and
94% (80e100), respectively. ROC analysis provided AUC of
0.91 (standard error 0.07). The interobserver agreement for
the binary score was excellent (k ¼ 0.91, p < .001).
Median (IQR) SUVmax in all vascular grafts was 6.3 (4.4e
8.5), whereby median SUVmax was higher in patients with
proven graft infections than in patients with no infected
grafts (6.7 [5.8e10] vs. 3.2 [2.8e3.6]; p < .001) (Fig. 2). In
our study population, six of seven patients (86%) without
graft infection had SUVmax  3.6, while all patients (27/27)
with graft infections had SUVmax  3.8 (Table 2). Hence an
SUVmax of 3.8 was determined as a cut off value to
differentiate between infected and non-infected grafts
(100% [87e100] sensitivity and 86% [42e100] speciﬁcity).
In two patients with PVGIs a coincident malignant disease
was diagnosed, one hypopharyngeal carcinoma and one
gastrointestinal stromal tumor.
Seven patients had no graft infection. FDG-PET/CT pro-
vided a conclusive clinical diagnosis in line with the pa-
tient’s symptoms in all patients, including infections other
than a PVGI: pneumonia (n ¼ 1), colitis (n ¼ 2), diverticulitis
(n ¼ 1), sinusitis (n ¼ 1), and spondylodiscitis (n ¼ 1). One
of the seven patients had Dressler syndrome (not detected
by PET/CT). All of these patients had a 6 month follow up
visit at our institution and neither clinical information nor
subsequent imaging pointed towards a PVGI.
DISCUSSION
Suspected vascular graft infections are still primarily inves-
tigated by CT scan despite the superiority of FDG-PET/CT
over CT in the diagnostic assessment of patients with
PVGIs suggested in recent years.2 Results of this study
support the knowledge that the diagnostic accuracy of FDG-Figure 2. Receiver operator curve (ROC) of prosthetic vascular graft
infection using the SUVmax as a quantitative measurement of
tracer uptake. A SUVmax of3.8 was determined as cut off value to
differentiate between infected and non-infected grafts (100%
sensitivity and 75% speciﬁcity). SUVmax ¼ maximum standardized
uptake value; AUC ¼ area under the curve.PET/CT in patients with suspected PVGI may even be higher
than previously reported, provided that patients are imaged
prior to antibiotic treatment, and that the newly introduced
visual grading score is used for image interpretation.
Patient population
The diagnosis of a PVGI is often delayed and as yet there are
no clear diagnostic criteria available. Detection of micro-
organisms in the perigraft tissue may serve as a gold stan-
dard for this complicated diagnosis. Ninety-six percent of
our patients had a microbiologically proven graft infection,
whereas in previous studies4e6 positive culture results were
available in only 0e64% of the study population, presum-
ably due to prolonged antibiotic therapy prior to hospital
admission. The current study population included fewer
patients on antimicrobial treatment prior to imaging (22/34,
65%), reﬂecting a mixed study population of low grade and
acute graft infections. Fukuchi et al.4 enrolled 26 patients
with suspected graft infection (plus 7 asymptomatic con-
trols); 25 patients (79%) had received antibiotic treatment
at the time of imaging. Seventeen of 25 (68%) patients had
been treated with intensive antibiotic treatment in the
study population of Bruggink et al.7 Clinical presentation
may be acute in some patients with vascular graft in-
fections, especially in the presence of highly virulent path-
ogens,15 requiring immediate antimicrobial treatment. After
the start of effective antibiotic treatment, a trend to
declining metabolic activity in infections is expected,7 which
might reduce the sensitivity of FDG-PET/CT.
High levels of blood glucose and/or high levels of blood
insulin may reduce the sensitivity of FDG PET/CT, although
data in the literature are somewhat controversial.16 Fukuchi
et al.4 excluded patients with diabetes, whereas Keidar
et al.5 included eight patients with diabetes in their study
population of 39 patients, six of them with normal blood
glucose levels; one of these six was diagnosed as FN, which
was probably due to high levels of insulin. None of the ﬁve
patients in this study with diabetes was rated FN or FP;
which might account for the improved diagnostic accuracy
compared with the other studies mentioned above.
Diagnostic accuracy
Data on diagnostic accuracy of FDG-PET/CT in the detection
of PVGI are sparse and reliability is hampered by large vari-
ability of patient populations. Only four groups have pro-
spectively investigated patient populations of more than 10
patients with suspected vascular graft infections.4e7 All of
these studies have demonstrated that FDG-PET/CT is a highly
sensitive method for the diagnosis of PVGIs (sensitivities
91%, 93%, 93%, and 98%). However, speciﬁcity was rather
low (64%, 70%, 76%, and 91%). FP ﬁndings may occur in the
presence of an infected hematoma, a lymphocele in the
vicinity of the graft,10 or as a result of foreign body re-
actions.4e6,10,17 Moreover, limitations exist in the distinction
of foreign body reaction and low grade infection in the
presence of inhomogeneous FDG uptake in PET/CT.6 There-
fore, the ﬁve point visual grading score introduced herein for
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take, as suggested by Bruggink et al.,7 with uptake pattern
(focal or diffuse) as well as CT information (i.e., ﬂuid or gas
formations). The diagnostic accuracy in the present study is
higher than in all previous studies,4e7 reaching 100% accu-
racy in the subgroup with no antimicrobial treatment prior to
imaging.Whether this is due to a favorable recruitment, or to
the beneﬁcial performance of the newly introduced imaging
score, will be matter of further studies.
SUVmax cut off value
An FP PVGI diagnosis may lead to unnecessarily complex
multimodal treatment, whereas a FN diagnosis is associated
with highmorbidity.2 An adequate SUVmax cut off valuemay be
helpful in clinical routine to differentiate graft infection from a
non-infectious process especially in equivocal cases. Spacek
et al.6 suggested an SUVmax of 1.7 as a cut off value, while
Tokuda et al.11 suggested an SUVmax> 8 to distinguish infected
grafts from non-infected grafts. The former determined the
SUVmax cut off value using ROC analyses for the best accuracy
of FDG-PET/CT in detecting PVGI, while the latter measured
the optimal SUVmax cut off value by determining maximal
sensitivity and speciﬁcity at the ROC curve (Youden test).
Apparently, methodological methods were different and re-
ported patient populations too heterogeneous with regard to
clinical presentation and sample size and do not yet allow
reliable deﬁnition of SUVmax cut off values. Further validating
study results are mandatory before introducing SUVmax cut off
values into routine clinical use. However, SUVmax cut off values
could serve as an interesting monitoring tool for the response
to antibiotic treatment in the future.
Limitations of the study
The present study population is heterogeneous, similar to
all populations of previous studies.4e7 However, by means
of the standardized cohort procedures the percentage of
patients receiving antimicrobial treatment prior to imaging
was reduced. Further improvement might even increase the
accuracy of FDG-PET/CT in future studies, however, due to
the severity of the disease, it will be a difﬁcult task. Addi-
tionally, the usefulness of PET/CT is limited by its relative
unavailability in emergency cases.
CONCLUSION
The diagnostic accuracy of FDG-PET/CT in patients with
suspected vascular graft infection is very high. This study
suggest that the newly introduced ﬁve point visual grading
score and avoiding antimicrobial treatment prior to imaging
may increase the diagnostic accuracy to even higher values.
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